Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cardium Therapeutics, a medical technology company, has announced that its operating unit InnerCool Therapies has received a new supplier contract from Novation to introduce InnerCool's RapidBlue endovascular patient temperature modulation system into Novation's network of member healthcare systems, which includes thousands of hospitals throughout the US.
Subscribe to our email newsletter
The agreement, effective January 1, 2009, has a three-year initial term and includes an option to extend for two additional years.
InnerCool’s RapidBlue System is a thermal regulating system designed to manage and control patient body temperature. RapidBlue provides rapid or gradual temperature control for all patient sizes. Its closed loop catheter-based system modulates whole body temperature, without fluid introduction or exchange, by circulating cool or warm saline within the interior of the catheter.
Christopher Reinhard, chairman and CEO of Cardium Therapeutics and InnerCool Therapies, said: “We are pleased to partner with Novation, the nation’s leading group purchasing organization. The award of this key supplier contract marks another important milestone in the growing market acceptance of our patient temperature modulation solutions.”